Author Question: In the Susan G. Komen for the Cure-Planned Parenthood case, the Komen board made which of the ... (Read 123 times)

joe

  • Hero Member
  • *****
  • Posts: 627
In the Susan G. Komen for the Cure-Planned Parenthood case, the Komen board made which of the following public relations errors?
 
  A) They the utilized compulsory-advisory management model.
  B) They did not listen to individual board members with unpopular opinions.
  C) They responded to the media too quickly.
  D) They relegated public relations to a purely advisory role.
  E) They caved in to outside pressure too easily.

Question 2

Small-scale organizations of low complexity usually have public relations working in roles that are primarily
 
  A) managerial.
  B) compulsory-advisory.
  C) technical.
  D) concurring authority.
  E) consulting.


momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

Answer: D

Answer to Question 2

Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

Adult head lice are gray, about ? inch long, and often have a tiny dot on their backs. A female can lay between 50 and 150 eggs within the several weeks that she is alive. They feed on human blood.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library